Enhance Understanding of Novel Therapeutics for Breast Cancer
Join Dr. Nick Zdenkowski for an insightful commentary on breast cancer therapeutics. He will cover the latest clinical trial results and emerging therapies, including CDK4/6 inhibitors, antibody-drug conjugates (ADCs), endocrine therapy, and PARP inhibitors. Dr. Zdenkowski will discuss the mechanisms of action, efficacy, and safety profiles of these treatments.